[go: up one dir, main page]

WO2009138198A3 - Compositions comprenant de l'hydroxytyrosol pour le traitement préventif et curatif de troubles du tractus intestinal - Google Patents

Compositions comprenant de l'hydroxytyrosol pour le traitement préventif et curatif de troubles du tractus intestinal Download PDF

Info

Publication number
WO2009138198A3
WO2009138198A3 PCT/EP2009/003317 EP2009003317W WO2009138198A3 WO 2009138198 A3 WO2009138198 A3 WO 2009138198A3 EP 2009003317 W EP2009003317 W EP 2009003317W WO 2009138198 A3 WO2009138198 A3 WO 2009138198A3
Authority
WO
WIPO (PCT)
Prior art keywords
hydroxytyrosol
intestinal tract
compositions
preventive
curative treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/003317
Other languages
English (en)
Other versions
WO2009138198A2 (fr
Inventor
Felicia Cisale
Luciano Villanova
Azzurra Villanova
Alessandro Merendino
Gianluca Fasiello
Luigi Villanova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lachifarma Srl Laboratorio Chimico Farmaceutico Salentino
Original Assignee
Lachifarma Srl Laboratorio Chimico Farmaceutico Salentino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lachifarma Srl Laboratorio Chimico Farmaceutico Salentino filed Critical Lachifarma Srl Laboratorio Chimico Farmaceutico Salentino
Publication of WO2009138198A2 publication Critical patent/WO2009138198A2/fr
Publication of WO2009138198A3 publication Critical patent/WO2009138198A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur des compositions orales présentant une libération améliorée dans le tractus intestinal, lesquelles contiennent de l'hydroxytyrosol comme principe actif, et, le cas échéant, des fibres alimentaires solubles.
PCT/EP2009/003317 2008-05-14 2009-05-11 Compositions comprenant de l'hydroxytyrosol pour le traitement préventif et curatif de troubles du tractus intestinal Ceased WO2009138198A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2008A000869 2008-05-14
IT000869A ITMI20080869A1 (it) 2008-05-14 2008-05-14 Composizioni a base di idrossitirosolo per il trattamento preventivo e curativo di patologie del tratto intestinale

Publications (2)

Publication Number Publication Date
WO2009138198A2 WO2009138198A2 (fr) 2009-11-19
WO2009138198A3 true WO2009138198A3 (fr) 2010-03-04

Family

ID=40302738

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/003317 Ceased WO2009138198A2 (fr) 2008-05-14 2009-05-11 Compositions comprenant de l'hydroxytyrosol pour le traitement préventif et curatif de troubles du tractus intestinal

Country Status (2)

Country Link
IT (1) ITMI20080869A1 (fr)
WO (1) WO2009138198A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1623960A1 (fr) * 2004-08-06 2006-02-08 Lachifarma SRL Laboratorio Chimico Farmaceutico Salentino Procédé pour la récupération de tyrosol et hydroxytyrosol à partir des eaux usées provenant d'installations d'huilerie et procédé catalytique de conversion de tyrosol en hydroxytyrosol
US20060257351A1 (en) * 2001-10-09 2006-11-16 Fancel Corporation Compositions for potentiating glutatthione
WO2008006581A2 (fr) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Nouvelles compositions
EP2027781A1 (fr) * 2007-08-21 2009-02-25 DSMIP Assets B.V. Procédé pour éliminer le goût amer de l'extrait de jus d'olive

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257351A1 (en) * 2001-10-09 2006-11-16 Fancel Corporation Compositions for potentiating glutatthione
EP1623960A1 (fr) * 2004-08-06 2006-02-08 Lachifarma SRL Laboratorio Chimico Farmaceutico Salentino Procédé pour la récupération de tyrosol et hydroxytyrosol à partir des eaux usées provenant d'installations d'huilerie et procédé catalytique de conversion de tyrosol en hydroxytyrosol
WO2008006581A2 (fr) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Nouvelles compositions
EP2027781A1 (fr) * 2007-08-21 2009-02-25 DSMIP Assets B.V. Procédé pour éliminer le goût amer de l'extrait de jus d'olive

Also Published As

Publication number Publication date
ITMI20080869A1 (it) 2009-11-15
WO2009138198A2 (fr) 2009-11-19

Similar Documents

Publication Publication Date Title
WO2009064460A3 (fr) Systèmes de délivrance aux voies gastro-intestinales
WO2008128115A3 (fr) Formulations de doxépine à faible dose et procédé de préparation et d'utilisation de celle-ci
CA3094580C (fr) Formulations orales d'analogues de cytidine et leurs procedes d'utilisation
WO2008151299A3 (fr) Dispositifs medicaux implantables de traitement local et regional
EP4538227A3 (fr) Compositions pharmaceutiques contenant du thiosulfate de sodium
IL207038A (en) History of Diazaspiro [5.5] Undecan, Pharmaceuticals Containing them, and their use in the preparation of drugs for the treatment or reduction of the risk of disease or inflammatory condition
WO2010069532A8 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
WO2010132882A8 (fr) Compositions sublinguales de dexmédétomidine et leurs procédés d'utilisation
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
WO2007135193A3 (fr) Forme pharmaceutique orale multimicroparticulaire a liberation prolongee comprenant des moyens anti-mesusage et resistant a l'alcool
MY152279A (en) Immediate release pharmaceutical compositions comprising oxycodone and naloxone
WO2010062581A3 (fr) Composition botanique pour une réparation cutanée optimisée et utilisations associées
WO2007109160A3 (fr) Composés de bicyclohétéroaryle en tant que modulateurs de p2x7 et leurs utilisations
WO2009073307A3 (fr) Dispositifs médicaux implantables pour traitement local ou zonal
WO2011037411A3 (fr) Composition comprenant une s-allyl-l-cystéine à titre de principe actif pour prévenir ou traiter les troubles gastro-intestinaux
WO2009068708A8 (fr) Composition pharmaceutique à libération prolongée de somatostatine ou d'un analogue de celle-ci
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
WO2011044523A3 (fr) Compositions et procédés destinés à traiter l'obésité
WO2009142428A3 (fr) Composition pharmaceutique destinée au traitement de l'éjaculation précoce
WO2007083190A8 (fr) Extrait d'helychrisum insoluble dans l'eau, et procédés d'élaboration et d'utilisation correspondants
EP2196463A4 (fr) Procédé de préparation d'acide 5,6-diméthylxanthone-acétique, dérivés ainsi obtenus et formulations pharmaceutiques de ceux-ci
WO2012040082A3 (fr) Compositions pharmaceutiques solides antidiabétiques
WO2010079433A3 (fr) Composition pharmaceutique qui comprend un inhibiteur de la dipeptidyl peptidase-iv
WO2008094054A3 (fr) Composés

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09745532

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09745532

Country of ref document: EP

Kind code of ref document: A2